Primary Peritoneal Carcinoma Recruiting Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02124421Outcomes in CRS/HIPEC as Initial Treatment of Ovarian, Fallopian Tube and Primary Peritoneal CancerTreatment
NCT03783949European Trial on Enhanced DNA Repair Inhibition in Ovarian CancerTreatment